BIRC5 and cancer: Increased survivin expression is associated with a worse prognosis in various cancers, e.g., lung [14], colon [15], bladder [16] and prostate cancer [17], reduced apoptosis, worse response to treatment (chemotherapy) and shortened survival in patients [18,19].